Flordaliza, Rosenito G.
HRN: 09-45-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
CO-AMOXICLAV 625MG (TAB)
02/05/2024
02/10/2024
PO
625mg
BID
Fracture
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes